Cyclodextrin complexes of salts of acidic drugs. Thermodynamic properties, structural features, and pharmaceutical applications

Journal of Pharmaceutical Sciences

Volumn 90, Issue 8, 2001, Pages 979-986

  Redenti, Enrico ^a   Szente, Lajos ^b   Szejtli, Josef ^b  

^a CHIESI FARMACEUTICI S P A   (Italy)

^b CycloLab Cyclodextrin Research & Development Laboratory Ltd   (Hungary)

Author keywords

Acidic drugs; Cyclodextrin; Inclusion complexes; Salt

Indexed keywords

AMINO ACID; ANION; ANTIDIABETIC AGENT; BETA CYCLODEXTRIN; BILE ACID; BILE SALT; CHLOROTHIAZIDE; CYCLODEXTRIN DERIVATIVE; DICLOFENAC; DIURETIC AGENT; FENOPROFEN; FLURBIPROFEN; FUROSEMIDE; GLIBENCLAMIDE; GLICLAZIDE; HYDROXYLAMINE; IBUPROFEN; INDOMETACIN; KETOPROFEN; NAPROXEN; NIMESULIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PHENOLPHTHALEIN; PIROXICAM; PROPIONIC ACID DERIVATIVE; SODIUM; SULFONYLUREA DERIVATIVE; URSODEOXYCHOLIC ACID; VALPROIC ACID;

CLINICAL TRIAL; COMPLEX FORMATION; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG FORMULATION; DRUG SOLUBILITY; DRUG STABILITY; DRUG STRUCTURE; HUMAN; NONHUMAN; PH; PHOTODEGRADATION; PHYSICAL CHEMISTRY; SHORT SURVEY; STOICHIOMETRY; THERMODYNAMICS; THERMOSTABILITY;

EID: 0034887576     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1002/jps.1050     Document Type: Short Survey

References (73)

1. Indomethacin
2. Some pharmacokinetic properties and bioavailability by oral and rectal route of piroxicam in rodents and man
3. Update on ibuprofen
4. Nimesulide
5. Aqueous solubility and acidity constant of cholic, dexoxycholic, chenodeoxycholic and ursodeoxycholic acids
6. Pharmacokinetics and metabolic effects of glibenclamide and glipizide in type 2 diabetes
7. Gliclazide
8. Novel formulation strategies for improving oral bioavailability of drugs with poor membrane permeation or presystemic metabolism
9. A theoretical basis for a biopharmaceutical drug classification: The correlation of in vitro drug product dissolution and in vivo bioavailability
10. In vitro absorption studies and their relevance to absorption from the GI tract
11. Influence of physicochemical properties on dissolution of drugs in the gastrointestinal tract
12. Pharmaceutical applications of cyclodextrins. 2. In vivo drug delivery
13. Pharmaceutical salts
14. The History of diclofenac
15. Ibuprofen arginine in the management of pain
16. Application of cyclodextrins
17. Pharmaceutical applications of cyclodextrins. 1. Drug solubilisation and stabilization
18. Inclusion complexes between non steroidal antiinflammatory drugs and β-cyclodextrin
19. Potentiometric study of molecular complexes of weak acids and bases applied to complexes of α-cyclodextrin with para-substituted benzoic acids
20. Cyclodextrin complexation of NSAIDs: Physicochemical characteristics
21. Complexation of bile acids with β-cyclodextrin
22. The interaction of charged and uncharged drugs with neutral (HP-β-CD) and anionically charged (SBE7-β-CD) β-cyclodextrins
23. Thermodynamic analysis of the binding of a hepatoprotector drug, thioctic acid, by β-cyclodextrin
24. Preparation and characterization of piroxicam alkali-salt γ-cyclodextrin complexes
25. Piroxicam sodium: Effect of inclusion complexation with β-cyclodextrin
26. The crystal structure of the inclusion complex of the sodium salt of piroxicam with cyclodextrin
27. Proton nuclear magnetic resonance spectroscopy studies of the inclusion complex of piroxicam with β cyclodextrin
28. Indomethacin and cyclodextrin complexes
29. High-field nuclear magnetic resonance techniques for the investigation of a β-cyclodextrin: Indomethacin inclusion complex
30. 1H NMR and molecular modeling study of the inclusion complex β-cyclodextrin-indomethacin
31. Enhanced pharmacokinetic properties of oral and parenteral diclofenac-cyclodextrin delivery systems
32. Stability of dicofenac sodium in the inclusion complex with β-cyclodextrin in the solid state
33. Synthesis and X-ray crystal structure of β-cyclodextrin diclofenac sodium undecahydrate, a β-CD complex with an unique crystal packing arrangement
34. X-ray structures and thermal analyses of new CD/drug inclusion compounds
35. Desorption of water from CD/drug inclusion complexes. Thermal behavior-crystal structure correlation
36. NMR spectroscopy of inclusion complex of sodium diclofenac with β-cyclodextrin in aqueous solution
37. Diclofenac-beta-cyclodextrin inclusion in solution: Proton magnetic resonance and molecular modeling studies
38. Interaction of diclofenac sodium with β- and hydroxypropyl-β-cyclodextrin in Solution. ST.P
39. 13C NMR study on diclofenac/β-cyclodextrin and diclofenac 2-hydroxypropyl-β-cyclodextrin systems
40. Isostructural replacement of an N-H···O by a C-H···O hydrogen bond in complex stabilisation: Crystal structures of β-cyclodextrin complexed with diethanolamine and with pentane-1,5-diol
41. Drug/cyclodextrin/hydroxy acid multicomponent systems. Properties and pharmaceutical applications
42. Control of NSAID dissolution by β-cyclodextrin complexation
43. Carbon-13 nuclear magnetic resonance study of naproxen interaction with cyclodextrins in solution
44. NMR investigation of the interaction of (+)- and (-)-flurbiprofen with β-cyclodextrin
45. Stereochemistry and dynamics of the inclusion complex of (S)-(+)-fenoprofen with cyclomaltoheptaose
46. In vitro and in vivo studies on sodium nimesulide-β-cyclodextrin inclusion complex
47. Study of the influence of both cyclodextrins and L-lysine on the aqueous solubility of nimesulide; Isolation and characterization of nimesulide-L-lysine-cyclodextrin complexes
48. Absorption studies on orally administered glibenclamide and glibencalmide/sodium/β-cyclodextrin complex in rabbits
49. Structural characterization of glibenclamide sodium salt inclusion complex with cyclodextrin
50. Nuclear magnetic resonance investigations of the inclusion complexation of gliclazide with cyclodextrin
51. Multicomponent non-covalent associations of β-cyclodextrin (β-CD)-drug inclusion complexes with diethanolamine (DEA). Detection and characterization of gaseous protonated 1:1:1 β-CD-Drug-DEA Adducts by Ionspray Ionization and Tandem Mass Spectrometry
52. Interaction of β-cyclodextrin with bile salts in aqueous solution
53. Studies on complexation between β-cyclodextrin and bile salts
54. Formation of inclusion complexes of cyclodextrins with bile salt anions as determined by NMR titration studies
55. Transient binding mode of phenolphthalein-β-cyclodextrin complex: The lactone dianion as an induced transition-state analog trapped in β-cyclodextrin
56. Preparation and evaluation of dermatological formulations based on inclusion of tretinoin in β-cyclodextrin and hydroxypropyl-β-cyclodextrin
57. Role of the development scientist in compound lead selection and optimisation